Ciena

Arrowhead Pharmaceuticals

Onespaworld Holdings

S&P Dow Jones Indices Announces Changes to S&P 500, S&P MidCap 400, and S&P SmallCap 600

ADT: A Defensive Business with Undervalued Shares and Potential ROIC Gains

ADT: Market Undervalues This Business Due to Unwarranted Share Price Performance

Macy's

Macy's: The Bull of the Day, ADT: The Bear of the Day

Morgan Stanley maintains Equal-Weight rating on ADT, cuts PT to $9.

Catalyst<ul> <li>Fund flow analysis indicates positive inflow across all order size buckets, suggesting strong investor confidence in ADT.</li></ul>Risk<ul> <li>Technical indicators show that bearish signals are clearly dominant with no bullish signals recently, indicating a potential downside risk for ADT.</li> <li>The latest technical signal, a Long Upper Shadow, has a negative polarity and suggests a biased bearish outlook.</li></ul>

Key Factors

ADT Inc. joined the S&P SmallCap 600 index, replacing Arrowhead Pharmaceuticals Inc. in the index.

Recent Updates

ADT News